EA200101228A1 - USE OF ANTIBODIES THAT RECOGNIZE THE INTERLEUKIN-2 RECEPTOR FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS CAUSED BY AIDS VIRUSES - Google Patents

USE OF ANTIBODIES THAT RECOGNIZE THE INTERLEUKIN-2 RECEPTOR FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS CAUSED BY AIDS VIRUSES

Info

Publication number
EA200101228A1
EA200101228A1 EA200101228A EA200101228A EA200101228A1 EA 200101228 A1 EA200101228 A1 EA 200101228A1 EA 200101228 A EA200101228 A EA 200101228A EA 200101228 A EA200101228 A EA 200101228A EA 200101228 A1 EA200101228 A1 EA 200101228A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
treatment
interleukin
receptor
infections caused
Prior art date
Application number
EA200101228A
Other languages
Russian (ru)
Inventor
Пьер-Франсуа Серр
Original Assignee
Иппокамп
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иппокамп filed Critical Иппокамп
Publication of EA200101228A1 publication Critical patent/EA200101228A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Использование антител или аналогов, которые блокируют рецептор интерлейкина-2, для предотвращения прикрепления вируса СПИДа к его клеткам-мишеням и/или его проникновения внутрь указанных клеток. Использование в лечении инфекций, вызываемых вирусом СПИДа.Международная заявка была опубликована вместе с отчетом о международном поиске.The use of antibodies or analogs that block the receptor interleukin-2, to prevent the attachment of the AIDS virus to its target cells and / or its penetration into these cells. Use in the treatment of infections caused by the AIDS virus. The international application was published along with an international search report.

EA200101228A 1999-05-21 2000-05-22 USE OF ANTIBODIES THAT RECOGNIZE THE INTERLEUKIN-2 RECEPTOR FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS CAUSED BY AIDS VIRUSES EA200101228A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906528A FR2793691B1 (en) 1999-05-21 1999-05-21 USE OF ANTIBODIES RECOGNIZING THE INTERLEUKIN-2 RECEPTOR IN THE PREVENTION AND / OR TREATMENT OF AIDS VIRUS INFECTIONS
PCT/FR2000/001399 WO2000071159A1 (en) 1999-05-21 2000-05-22 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections

Publications (1)

Publication Number Publication Date
EA200101228A1 true EA200101228A1 (en) 2002-08-29

Family

ID=9545913

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101228A EA200101228A1 (en) 1999-05-21 2000-05-22 USE OF ANTIBODIES THAT RECOGNIZE THE INTERLEUKIN-2 RECEPTOR FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS CAUSED BY AIDS VIRUSES

Country Status (8)

Country Link
EP (1) EP1178827A1 (en)
AP (1) AP2001002354A0 (en)
AU (1) AU4930300A (en)
CA (1) CA2373991A1 (en)
EA (1) EA200101228A1 (en)
FR (1) FR2793691B1 (en)
OA (1) OA12311A (en)
WO (1) WO2000071159A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2401136T3 (en) 2002-11-15 2013-04-17 Genmab A/S Human monoclonal antibodies against CD25

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (en) * 1988-05-06 1989-11-16 Centre Regional De Transfusion MONOCLONAL ANTICOERPER AND ITS USE
JPH024800A (en) * 1988-06-24 1990-01-09 Ube Ind Ltd Module for removing interleukin ii receptor and method for removing interleukin ii receptor using said module
HUT60768A (en) * 1990-03-16 1992-10-28 Sandoz Ag Process for producing cd25 fixing molecules
JPH05244982A (en) * 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd Humanized b-b10

Also Published As

Publication number Publication date
FR2793691B1 (en) 2003-10-03
EP1178827A1 (en) 2002-02-13
AU4930300A (en) 2000-12-12
CA2373991A1 (en) 2000-11-30
WO2000071159A1 (en) 2000-11-30
FR2793691A1 (en) 2000-11-24
AP2001002354A0 (en) 2001-12-31
OA12311A (en) 2006-05-12

Similar Documents

Publication Publication Date Title
ATE466932T1 (en) REPRODUCTION OF VIRUSES IN CELL CULTURE
EA200300023A1 (en) 3'-PROCEDURES 2'-DEOXY-β-L-NUCLEOSIDES
EA200000840A1 (en) ANTI-VIRUS DERIVATIVES OF PYRIMIDINE
EA200500723A1 (en) COMPOUNDS OF BENZOFURANE, COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF INFECTIONS, CAUSED BY THE HEPATITIS C VIRUS, AND RELATED DISEASES
EA200200401A1 (en) ANTI-VIRUS COMPOSITIONS
EA200400241A1 (en) MULTIMERAL CONTRAST SUBSTANCES BASED ON PEPTIDES ARE DIRECTED TO A TARGET
EA199901031A1 (en) Derivatives of benzimidazole
EA200400991A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INHIBITORS OF THE HEPATITIS VIRUS VIRUS PROTEASE
EA200300919A1 (en) N-SUBSTITUTED NON-ARYL HETEROCYCLIC ANTAGONISTS NMDA / NR2B
ATE355380T1 (en) METHOD FOR SELECTIVE INACTIVATION OF VIRAL REPLICATION
EA200200105A1 (en) Compounds modulating PPARγ activity;
EA200100315A1 (en) SIMPLE TETRAHYDROPYRIDE ETHERS
EA200301215A1 (en) 5-HT RECEPTOR LIGANDS AND THEIR APPLICATION
EA199801031A1 (en) PROTEINFARNESILTRANSFERASE INHIBITORS
EA200100012A1 (en) BRIDGES INDENOPYRROCARBAZOLES
GT200600262A (en) USE OF SANGLIFERINE IN HCV (HEPATITIS VIRUS "C")
EA201000277A1 (en) CONNECTIONS FOR THE TREATMENT OF HEPATITIS C
EA200100362A1 (en) METHODS OF TREATMENT OF MULTIPLE MYELOMA AND INDUCED MYELOUS BONE RESORPTION BY MEANS OF ANTAGONISTS INTEGRINES
EA200200545A1 (en) ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT
EA200200974A1 (en) MONOCLONAL ANTIBODIES TO THE HUMAN LDL RECEPTOR, THEIR RECEIVING AND APPLICATION
EA200501046A1 (en) ESCITALOPRAMHYDROBROMID AND WAY TO OBTAIN IT
DE69704180D1 (en) Antivirus compounds
DE69703672D1 (en) Antivirus compounds
EA200101228A1 (en) USE OF ANTIBODIES THAT RECOGNIZE THE INTERLEUKIN-2 RECEPTOR FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS CAUSED BY AIDS VIRUSES
EA199900235A1 (en) AMORPHOUS BENZOTHYPHENES, METHODS OF OBTAINING AND METHODS OF APPLICATION